Ir para o conteúdo principal

Grafa News and Videos — Page 973

Destaques de Grafa

Grafa

Henlius and Organon secure EC approval for POHERDY, Europe’s first Pertuzumab biosimilar

Shanghai Henlius Biotech and Organon (NYSE:OGN) announced on Wednesday, April 29, 2026, that the European Commission (EC) has granted marketing authorization for POHERDY (pertuzumab), making it the first and only approved biosimilar to the reference product PERJETA in Europe.

Leia mais: Henlius and Organon secure EC approval for POHERDY, Europe’s first Pertuzumab biosimilar

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas